4//SEC Filing
BOVIE MEDICAL CORP 4
Accession 0001140361-15-012452
$APYXCIK 0000719135operating
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 3:56 PM ET
Size
14.3 KB
Accession
0001140361-15-012452
Insider Transaction Report
Form 4
Sheffield Ian
Director10% Owner
Transactions
- Award
Common Stock
2015-03-17$2.50/sh+480,000$1,200,000→ 480,000 total(indirect: See footnote 1) - Disposition to Issuer
Common Stock Warrants (right to buy)
2015-03-17+5,250,000→ 0 total(indirect: See Footnote 1)→ Common Stock (5,250,000 underlying) - Award
Series B Convertible Preferred Stock
2015-03-17+3,588,139→ 3,588,139 total(indirect: See Footnote 1)→ Common Stock (7,176,278 underlying) - Disposition to Issuer
Series A Convertible Preferred Stock
2015-03-17+3,500,000→ 0 total(indirect: See Footnote 1)→ Common Stock (3,500,000 underlying)
GREAT POINT PARTNERS LLC
10% Owner
Transactions
- Award
Common Stock
2015-03-17$2.50/sh+480,000$1,200,000→ 480,000 total(indirect: See footnote 1) - Award
Series B Convertible Preferred Stock
2015-03-17+3,588,139→ 3,588,139 total(indirect: See Footnote 1)→ Common Stock (7,176,278 underlying) - Disposition to Issuer
Series A Convertible Preferred Stock
2015-03-17+3,500,000→ 0 total(indirect: See Footnote 1)→ Common Stock (3,500,000 underlying) - Disposition to Issuer
Common Stock Warrants (right to buy)
2015-03-17+5,250,000→ 0 total(indirect: See Footnote 1)→ Common Stock (5,250,000 underlying)
Footnotes (2)
- [F1]The amounts shown represent the beneficial ownership of the issuer's securities by funds and certain managed accounts managed by Great Point Partners LLC (the "GPP Investors"), which may be deemed attributable to Mr. Sheffield. Mr. Sheffield serves as a director of the issuer as a representative of Great Point Partners LLC acting on behalf of the GPP Investors, and accordingly Great Point Partners LLC and the GPP Investors may be deemed to be a director by deputization. Great Point Partners, LLC and Mr. Sheffield each disclaim beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F2]On March 17, 2015, the GPP Investors acquired 3,588,139 shares of Series B Preferred Convertible Stock in exchange for 3,500,000 shares of Series A 6% Convertible Preferred Stock and warrants to purchase up to 5,250,000 shares of the registrant's common stock. The Series B Convertible Preferred Stock is convertible at the option of the holder into shares of the registrant's common stock at a conversion ratio of one (1) share of Series B Convertible Preferred Stock to two (2) shares of common stock, subject to adjustments for stock dividends, splits, combinations and similar events.
Documents
Issuer
BOVIE MEDICAL CORP
CIK 0000719135
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000719135
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 3:56 PM ET
- Size
- 14.3 KB